118 related articles for article (PubMed ID: 7516363)
1. Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.
Torrani Cerenzia MR; Fiume L; Busi C; Mattioli A; Di Stefano G; Gervasi GB; Brunetto MR; Piantino P; Verme G; Bonino F
J Hepatol; 1994 Feb; 20(2):307-9. PubMed ID: 7516363
[No Abstract] [Full Text] [Related]
2. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.
Fiume L; Cerenzia MR; Bonino F; Busi C; Mattioli A; Brunetto MR; Chiaberge E; Verme G
Lancet; 1988 Jul; 2(8601):13-5. PubMed ID: 2455204
[TBL] [Abstract][Full Text] [Related]
3. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of woodchuck hepatitis virus replication by adenine arabinoside monophosphate coupled to lactosaminated poly-L-lysine and administered by intramuscular route.
Fiume L; Di Stefano G; Busi C; Mattioli A; Rapicetta M; Giuseppetti R; Ciccaglione AR; Argentini C
Hepatology; 1995 Oct; 22(4 Pt 1):1072-7. PubMed ID: 7557853
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial.
Zarski JP; Barange K; Souvignet C; Bertini M; Marcellin P; Tran A; Deugnier Y; Couzigou P; Plages A; Ambroise-Thomas P
J Hepatol; 2001 Mar; 34(3):486-8. PubMed ID: 11322216
[No Abstract] [Full Text] [Related]
6. Adenine arabinoside monophosphate and acyclovir monophosphate coupled to lactosaminated albumin reduce woodchuck hepatitis virus viremia at doses lower than do the unconjugated drugs.
Ponzetto A; Fiume L; Forzani B; Song SY; Busi C; Mattioli A; Spinelli C; Marinelli M; Smedile A; Chiaberge E
Hepatology; 1991 Jul; 14(1):16-24. PubMed ID: 1712338
[TBL] [Abstract][Full Text] [Related]
7. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
Marcellin P; Pouteau M; Loriot MA; Boyer N; Degos F; Calès P; Bettan L; Bacq Y; Coppére H; Grange JD
Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
[TBL] [Abstract][Full Text] [Related]
10. Antiviral treatment of chronic type B hepatitis.
Hoofnagle JH
Ann Intern Med; 1987 Sep; 107(3):414-5. PubMed ID: 2441635
[No Abstract] [Full Text] [Related]
11. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV
J Hepatol; 1986; 3 Suppl 2():S107-10. PubMed ID: 2439568
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
[TBL] [Abstract][Full Text] [Related]
14. Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects.
Torrani Cerenzia M; Fiume L; De Bernardi Venon W; Lavezzo B; Brunetto MR; Ponzetto A; Di Stefano G; Busi C; Mattioli A; Gervasi GB; Bonino F; Verme G
Hepatology; 1996 Apr; 23(4):657-61. PubMed ID: 8666314
[TBL] [Abstract][Full Text] [Related]
15. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication.
Perrillo RP
J Hepatol; 1986; 3 Suppl 2():S57-64. PubMed ID: 2439577
[TBL] [Abstract][Full Text] [Related]
16. Concurrent emergence of hepatitis B e antigen-negative hepatitis B virus variant and autoimmune hepatitis cured by adenine arabinoside monophosphate.
Bécheur H; Valla D; Loriot MA; Attar A; Bloch F; Petite JP
Dig Dis Sci; 1998 Nov; 43(11):2479-82. PubMed ID: 9824138
[TBL] [Abstract][Full Text] [Related]
17. Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.
Fiume L; Mattioli A; Busi C; Accorsi C
Gut; 1984 Dec; 25(12):1392-8. PubMed ID: 6210232
[TBL] [Abstract][Full Text] [Related]
18. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
[TBL] [Abstract][Full Text] [Related]
19. Liver targeting of adenine arabinoside monophosphate (ara-AMP) by coupling to lactosaminated human serum albumin.
Fiume L; Busi C; Di Stefano G; Mattioli A; Torrani-Cerenzia M; Bonino F; Capra G; De Bernardi W; Ponzetto A; Lavezzo B
Ital J Gastroenterol; 1995 May; 27(4):189-92. PubMed ID: 8520036
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
